fbpx

BlogMedicine & Treatments

The Thimble vs the Trash Can Why Brief is Better in Healthcare Communications

Our minds are like thimbles. They can hold only a little bit of content. When you pour too much information into a…

Read More →

Accentuate the Positive: Antipsychotics for Depression

Drug companies rarely lie to doctors outright. Their lies tend to be lies of omission. Drug companies subscribe to the popular adage…

Read More →

Something Smells Fishy − Prescription Drug Coupons

Getting Humira (adalimumab) for $5 a month seems like a deal made in heaven. But while being able to pay so little…

Read More →

The Ties That Bind − Topical Psoriasis Marketplace

I stopped treating my psoriasis years ago, when the exorbitant price of the topical fixed-combination corticosteroid my doctor prescribed made me throw…

Read More →

Fighting the Influence of Drug Marketing With Fire

If you want to win over clinician and consumer minds, stop complaining about — and instead start imitating — the way pharmaceutical…

Read More →

Altered Reality — Are Declining Cardiac Death Rates Attributable to Drugs

Sometimes I feel as if I live in an alternative reality. This seems particularly true when I see ads promoting drugs for…

Read More →

How Much Do You Know about Your Luxury Cardiac Procedure?

When it comes to healthcare, most consumers worship the newer, the more technologically advanced, and the most expensive. If an x-ray is…

Read More →

Risky Business — How Buying a Car is Like Oxycontin Drug Marketing

Opioid overdoses resulted in 399,230 deaths over the past two decades. There currently are 2,600 lawsuits accusing Purdue of aggressively marketing the benefits…

Read More →

Playing With Fire –The State of Pediatric Mental Health in America

I am the kind of person who makes mountains out of molehills. A friend of mine jokingly refers to me as “The…

Read More →

All that Glitas is Not Gold — Musings on Pharma Marketing & Type 2 Diabetes

The second-generation glitazones Avandia® (rosiglitazone) and Actos® (pioglitazone) — once touted as breakthrough drugs that could reduce cardiovascular mortality in patients with…

Read More →